Prollenium Unveils State-of-the-Art Training Facility for Medical Aesthetics

RICHMOND HILL, Ontario--(BUSINESS WIRE)-- Prollenium, a global leader in medical technology, proudly announces the launch of PACE Academy (Prollenium Advanced Clinical Education), a 5,000-square-foot facility dedicated to advanced training and education in medical aesthetics. This initiative marks a first-of-its-kind partnership with Harley Academy, a world leader in higher education for aesthetic medicine.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250225586578/en/

Prollenium's PACE Academy: A state-of-the-art medical aesthetics training facility in Richmond Hill, Ontario. (Photo: Business Wire)

Situated on Prollenium's campus in Richmond Hill, Ontario, PACE fosters collaboration among key opinion leaders, medical injectors, and industry professionals. The academy is equipped with innovative learning tools, including an Anatomage table with digitized cadavers—the first interactive technology of its kind available outside universities and hospitals. PACE also offers exclusive access to Prollenium's cutting-edge manufacturing facility, the only site in North America producing hyaluronic acid (HA) dermal fillers.

Harley Academy brings unparalleled expertise to PACE with evidence-based courses on injectables and cosmetic dermatology. The curriculum blends their proven training model—physician-led instruction, personalized mentoring, and a mix of online and hands-on sessions—with PACE's advanced tech environment. This partnership also features dedicated training sessions for Harley Academy students on Prollenium's Revanesse® range of dermal fillers.

"The opening of PACE marks a significant milestone for Prollenium, bridging a crucial gap in the industry where professionals can engage with groundbreaking technology and elevate their expertise," said Ario Khoshbin, Founder of Prollenium.

"PACE is designed to integrate with the technology and science we've developed and provide unprecedented access to advanced tools," Khoshbin added.

Prollenium, the only manufacturer of North American-produced HA dermal fillers, drives innovation and excellence in a rapidly growing multi-billion-dollar industry.

Media and industry partners are invited to tour the facility during its launch on February 27, 2025.

ABOUT PROLLENIUM

Prollenium leads the way in facial aesthetics and rejuvenation technology, turning complex science into reliable, effective products. As the first FDA-approved HA dermal filler manufacturer in North America, Prollenium redefines standards with cutting-edge innovation, exceptional safety, and a portfolio tailored to patient needs.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250225586578/en/

For media inquiries, please contact:
[email protected]

Source: Prollenium

You May Also Be Interested In

• Sygnia Reveals New Activity by China-Nexus Threat Actor Fire Ant Targeting Trusted Infrastructure
• Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026
• Ethereum ETFs Add $225.8M as IceBull Stage 1 Brings 1250X Potential Into the Best Crypto to Buy Now Race